StonvexLoading…
StonvexStonvexStonvexCore line items from NVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.24B | $3.89B | $2.83B | $1.77B |
Operating Income | $195.70M | $616.80M | $453.00M | $286.70M |
Net Income | $142.40M | $710.20M | $591.40M | $470.20M |
EPS (Diluted) | $0.87 | $4.31 | $3.59 | $2.84 |
Total Assets | $6.96B | $6.85B | $6.77B | $6.74B |
Total Liabilities | $3.17B | $3.12B | $3.14B | $3.22B |
Cash & Equivalents | $190.00M | $237.50M | $126.90M | $125.80M |
Free Cash Flow OCF − CapEx | $49.10M | $371.90M | $206.20M | $5.30M |
Shares Outstanding | 164.00M | 164.60M | 164.80M | 165.40M |